Printer-friendly versionPrinter-friendly version

Prevention and control of viral hepatitis in Spain: Lessons learnt and the way forward

Madrid, Spain, November 23-24, 2006

- Meeting Programme -

Thursday, November 23, 2006

Session 1 Opening and objectives
  
Chair: Nedret Emiroglu and Dionisio Herrera

09.00 - 09.20 

  • Welcome
  • Introduction of the participants
  • Introduction of the VHPB  529 Kb (.pdf)
  • Objectives of the meeting:
    1. Update of the epidemiological situation on viral hepatitis in Spain;
    2. Overview of surveillance systems for infectious diseases and adverse events following vaccination in Spain;
    3. Overview of the research activities on viral hepatitis in Spain;
    4. Evaluation of current prevention and control measures on viral hepatitis in Spain;
    5. Lessons learnt from the experience in Spain: successes, problems and barriers to overcome, and the way forward.
  • Review of the meeting programme
  • Pre-meeting document   416 Kb (.pdf)

Session 2 Setting the scene

Chair: Nedret Emiroglu and Dionisio Herrera

09.20 - 09.45
Organisation of the health care system in Spain 401 Kb (.pdf)
Patricia Santa Olalla Peralta, Madrid

09.45 - 10.10
Hepatitis vaccination policy in Spain  195 Kb (.pdf)
Patricia Santa Olalla Peralta, Madrid

10.10 - 10.35
National epidemiology surveillance network: hepatitis  1035 Kb (.pdf)
Carmen Varela, Madrid

10.35 - 10.55
Coffee break

Session 3 Hepatitis A and E

Chair: Daniel Lavanchy and Ángela Dominguez

10.55 - 11.20
Outbreaks of hepatitis A in Spain   825 Kb (.pdf)
Dionisio Herrera, Madrid

11.20 - 11.45
Molecular epidemiology of hepatitis A and E virus 733 Kb (.pdf)
Rosina Gironés, Barcelona

11.45 - 12.10
Vaccination against hepatitis A in Catalonia  177 Kb (.pdf)
Ángela Domínguez Garcia, Barcelona

12.10 - 12.35
Hepatitis E virus infections in Spain  2087 Kb (.pdf)
María Teresa Pérez Gracia, Valencia

12.35 - 14.00
Lunch

Session 4 Hepatitis B

Chair: Alessandro Zanetti and Pablo Barreiro

14.00 - 14.25
Hepatitis B virus genetic diversity in Spain 1659 Kb (.pdf)
Ana Avellón, Madrid

14.25 - 14.50
Molecular diagnosis of hepatitis B infection in the transfusional setting 178 Kb (.pdf)
Rocío González and Emma Castro, Madrid

14.50 - 15.10
Coffee break

 Session 5 Hepatitis C

Chair: Alessandro Zanetti and Pablo Barreiro

15.10 - 15.35
Epidemiology of hepatitis C  1118 Kb (.pdf)
Pablo Barreiro, Madrid

15.35 - 16.00
Molecular epidemiology of hepatitis C virus   1012 Kb (.pdf)
Josep Quer Sivila, Barcelona

Friday, November 24, 2006

Session 5  Hepatitis C - continued

Chair: Françoise Roudot-Thoraval and Mercedis Díez
 
09.30 - 09.55
Surveillance of viral hepatitis in hemodialysis units   1870 Kb (.pdf)
Guillermina Barril, Madrid

09.55 - 10.20
Prevalence of the HCV-HIV co-infection among mothers of newborn babies  324 Kb (.pdf)
Mercedis Díez, Madrid

10.20 -10.45
Coffee break

Session 6 Treatment of chronic viral hepatitis

Chair: Françoise Roudot-Thoraval and Mercedis Díez

10.45 - 11.10
Treatment of chronic hepatitis B  126 Kb (.pdf)
Jose M Sánchez-Tapias, Barcelona

11.10 -11.35
Treatment of chronic hepatitis C  170 Kb (.pdf)
Jose M Sánchez-Tapias, Barcelona

11.35 - 12.00
Management of the HIV co-infection in chronic viral hepatitis 
Cristina Tural, Barcelona
 
12.00 - 13.45
Lunch

Session 7 Conclusions and closing

Chair: Johannes Hallauer and Nicole Guérin

13.45 - 14.45
VHPB preliminary meeting conclusions 73 Kb (.pdf)
Daniel Shouval

14.45
Close of the meeting

Tags: